Dealmaking

Francisco Partners wins Deal of the Year; EQT takes home the prize for large market deals

Buyouts announces best private equity exits of 2021.

Inside the deal: Why STG Logistics, backed by Wind Point and Oaktree, bought XPO's intermodal biz

“There are still a lot of disruptions in the supply chain," said STG Logistics CEO Paul Svindland. "The demand to move goods is greater than the supply of capacity out there.”

Turnaround deal of the year: KPS Capital Partners and TaylorMade

TaylorMade was buried in the bunker until KPS made a brilliant sand save.

International Deal of the Year: Accel-KKR and Seequent

Accel-KKR saw that Seequent’s geological scanning software could dig much deeper than first thought, with far more applications possible.

Deal of the Year: Francisco Partners carves out Capsule with surgical precision

Scalpel! Francisco’s carve-out of Capsule Technologies, which provides patient monitoring and medical device integration, was just what the doctor ordered.

Deals of the year, and what a year it was

We toast the work of six private equity firms for their highly successful deals made in 2021. Francisco Partners takes the top prize with its carve-out of medical device maker Capsule Technologies.

Secondaries Deal of the Year: CD&R for Belron

The scale of the firm’s Belron deal set the bar high for GP-led single asset deals. And it’s clear as glass that GPs will be looking to beat it.

Large Market Deal of the Year: EQT and Aldevron

EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.

Small Market Deal of the Year: Argosy Capital Partners and Paragon

Argosy transforms Paragon from niche player in the nuclear power sector to predominant force.

Mid-market investment bank William Blair eyes GP-led secondaries advisory

Blair is one of several banks and financial advisers thinking about adding secondaries capabilities.